167 related articles for article (PubMed ID: 16575538)
1. Predicting which children are at risk for ependymoma relapse.
Sowar K; Straessle J; Donson AM; Handler M; Foreman NK
J Neurooncol; 2006 May; 78(1):41-6. PubMed ID: 16575538
[TBL] [Abstract][Full Text] [Related]
2. Gene expression patterns in ependymomas correlate with tumor location, grade, and patient age.
Korshunov A; Neben K; Wrobel G; Tews B; Benner A; Hahn M; Golanov A; Lichter P
Am J Pathol; 2003 Nov; 163(5):1721-7. PubMed ID: 14578171
[TBL] [Abstract][Full Text] [Related]
3. Ependymoma gene expression profiles associated with histological subtype, proliferation, and patient survival.
Lukashova-v Zangen I; Kneitz S; Monoranu CM; Rutkowski S; Hinkes B; Vince GH; Huang B; Roggendorf W
Acta Neuropathol; 2007 Mar; 113(3):325-37. PubMed ID: 17265049
[TBL] [Abstract][Full Text] [Related]
4. Identification of tumor-specific molecular signatures in intracranial ependymoma and association with clinical characteristics.
Modena P; Lualdi E; Facchinetti F; Veltman J; Reid JF; Minardi S; Janssen I; Giangaspero F; Forni M; Finocchiaro G; Genitori L; Giordano F; Riccardi R; Schoenmakers EF; Massimino M; Sozzi G
J Clin Oncol; 2006 Nov; 24(33):5223-33. PubMed ID: 17114655
[TBL] [Abstract][Full Text] [Related]
5. Identification of gains on 1q and epidermal growth factor receptor overexpression as independent prognostic markers in intracranial ependymoma.
Mendrzyk F; Korshunov A; Benner A; Toedt G; Pfister S; Radlwimmer B; Lichter P
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2070-9. PubMed ID: 16609018
[TBL] [Abstract][Full Text] [Related]
6. Merlin expression in pediatric anaplastic ependymomas real time PCR study.
Buccoliero AM; Castiglione F; Rossi Degl'Innocenti D; Sardi I; Genitori L; Taddei GL
Fetal Pediatr Pathol; 2010; 29(4):245-54. PubMed ID: 20594149
[TBL] [Abstract][Full Text] [Related]
7. Portrait of ependymoma recurrence in children: biomarkers of tumor progression identified by dual-color microarray-based gene expression analysis.
Peyre M; Commo F; Dantas-Barbosa C; Andreiuolo F; Puget S; Lacroix L; Drusch F; Scott V; Varlet P; Mauguen A; Dessen P; Lazar V; Vassal G; Grill J
PLoS One; 2010 Sep; 5(9):e12932. PubMed ID: 20885975
[TBL] [Abstract][Full Text] [Related]
8. Immune gene and cell enrichment is associated with a good prognosis in ependymoma.
Donson AM; Birks DK; Barton VN; Wei Q; Kleinschmidt-Demasters BK; Handler MH; Waziri AE; Wang M; Foreman NK
J Immunol; 2009 Dec; 183(11):7428-40. PubMed ID: 19917695
[TBL] [Abstract][Full Text] [Related]
9. Survival and prognostic factors following radiation therapy and chemotherapy for ependymomas in children: a report of the Children's Cancer Group.
Robertson PL; Zeltzer PM; Boyett JM; Rorke LB; Allen JC; Geyer JR; Stanley P; Li H; Albright AL; McGuire-Cullen P; Finlay JL; Stevens KR; Milstein JM; Packer RJ; Wisoff J
J Neurosurg; 1998 Apr; 88(4):695-703. PubMed ID: 9525716
[TBL] [Abstract][Full Text] [Related]
10. Specific chromosomal imbalances as detected by array CGH in ependymomas in association with tumor location, histological subtype and grade.
Rousseau A; Idbaih A; Ducray F; Crinière E; Fèvre-Montange M; Jouvet A; Delattre JY
J Neurooncol; 2010 May; 97(3):353-64. PubMed ID: 19865800
[TBL] [Abstract][Full Text] [Related]
11. Intracranial ependymoma: factors affecting outcome.
Massimino M; Buttarelli FR; Antonelli M; Gandola L; Modena P; Giangaspero F
Future Oncol; 2009 Mar; 5(2):207-16. PubMed ID: 19284379
[TBL] [Abstract][Full Text] [Related]
12. Differential expression and prognostic significance of SOX genes in pediatric medulloblastoma and ependymoma identified by microarray analysis.
de Bont JM; Kros JM; Passier MM; Reddingius RE; Sillevis Smitt PA; Luider TM; den Boer ML; Pieters R
Neuro Oncol; 2008 Oct; 10(5):648-60. PubMed ID: 18577562
[TBL] [Abstract][Full Text] [Related]
13. [Pediatric ependymomas: Current diagnosis and therapy].
Frappaz D; Vasiljevic A; Beuriat PA; Alapetite C; Grill J; Szathmari A; Faure-Conter C
Bull Cancer; 2016 Oct; 103(10):869-879. PubMed ID: 27717499
[TBL] [Abstract][Full Text] [Related]
14. Tumor vessel biology in pediatric intracranial ependymoma.
Wagemakers M; Sie M; Hoving EW; Molema G; de Bont ES; den Dunnen WF
J Neurosurg Pediatr; 2010 Apr; 5(4):335-41. PubMed ID: 20367336
[TBL] [Abstract][Full Text] [Related]
15. Ependymoma relapse goes along with a relatively stable epigenome, but a severely altered tumor morphology.
Yang D; Holsten T; Börnigen D; Frank S; Mawrin C; Glatzel M; Schüller U
Brain Pathol; 2021 Jan; 31(1):33-44. PubMed ID: 32633004
[TBL] [Abstract][Full Text] [Related]
16. Novel fusion genes and chimeric transcripts in ependymal tumors.
Olsen TK; Panagopoulos I; Gorunova L; Micci F; Andersen K; Kilen Andersen H; Meling TR; Due-Tønnessen B; Scheie D; Heim S; Brandal P
Genes Chromosomes Cancer; 2016 Dec; 55(12):944-953. PubMed ID: 27401149
[TBL] [Abstract][Full Text] [Related]
17. Expression profiling of ependymomas unravels localization and tumor grade-specific tumorigenesis.
Palm T; Figarella-Branger D; Chapon F; Lacroix C; Gray F; Scaravilli F; Ellison DW; Salmon I; Vikkula M; Godfraind C
Cancer; 2009 Sep; 115(17):3955-68. PubMed ID: 19536879
[TBL] [Abstract][Full Text] [Related]
18. [Preliminary study on the gene expression profiles of ependymomas with cDNA array].
Jiang RC; Pu PY; Shen CH; Jiao BH; Yu SZ; Kang CS; Wang CY; Wang GX
Zhonghua Wai Ke Za Zhi; 2003 Oct; 41(10):770-2. PubMed ID: 14766053
[TBL] [Abstract][Full Text] [Related]
19. Relapsed intracranial ependymoma in children in the UK: patterns of relapse, survival and therapeutic outcome.
Messahel B; Ashley S; Saran F; Ellison D; Ironside J; Phipps K; Cox T; Chong WK; Robinson K; Picton S; Pinkerton CR; Mallucci C; Macarthur D; Jaspan T; Michalski A; Grundy RG;
Eur J Cancer; 2009 Jul; 45(10):1815-23. PubMed ID: 19427780
[TBL] [Abstract][Full Text] [Related]
20. Preferential sites of metastatic relapse on MRI of initially localized ependymoma in children.
Rootman MS; Konen O; Fried I; Toledano H
Clin Imaging; 2017; 44():12-15. PubMed ID: 28395190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
